Table 4.

Percentage of enriched participants for each direct comparison

Direct comparisons
	PLB vs LIT	PLB vs VPA	PLB vs LTG	PLB vs IMP	PLB vs FLX	PLB LIT+IMP	PLB vs ARP	PLB vs OLZ	PLC vs QTP	PLB RisLAI	PLB vs PAL	LIT vs VPA	LIT vs CBZ	LIT vs LTG	LIT vs IMP	LIT vs LX	LIT vs LIT+IMP	LIT vs LIT+VPA	LIT vs LIT+OXC	LIT vs OLZ	LIT vs QTP	VPA vs LIT+VPA	VPA vs VPA+ARP	LTG vs VPA+LTG	LTG vs ARP+LTG	IMP vs LIT+IMP	OLZ vs RisLAl
Manic (%)	0	0	29	0	–	0	100	58	42	72	100	0	0	26	0	–	22	0	0	0	72	0	100	0	100	41	100
Depression (%)	0	0	79	0	100	0	0	0	58	0	0	0	0	76	0	100	25	0	0	0	28	0	0	100	0	46	0

ARP aripiprazole, CBZ carbamazepine, FLX fluoxetine, IMP imipramine, LIT lithium, LTG lamotrigine, OLZ olanzapine, OXC oxcarbazepine, PAL paliperidone, PLB placebo, QTP quetiapine, RisLAI risperidone long-acting injection, VPA valproate